Breakthrough in pain treatment for dogs with osteosarcoma

News Dogs - Breakthrough in pain treatment for dogs with osteosarcoma

between 6000-8000 dogs in the United States to receive treatment for osteosarcoma each year. ? Usually a disease of large breed dogs, osteosarcoma can affect the strains of all sizes. ? As the disease progresses, it restores normal healthy bone tissue and change the bones and throw. ? In dogs, as in people, this process becomes increasingly re-display more painful whenever the progression of the disease, which affects the activity levels and quality of life.

Dr. Vladimir Osipov Sarcomaimages.com

and Dorothy CIMINO Brown, DVM and Kimberly Agnello DVM University of Pennsylvania study

Seventy participated dogs who suffering from osteosarcoma in this study. ? Representing a variety of breeds, including Rottweiler, Golden Retrievers, Labrador retrieves and various mixed breeds. The average size of the dogs in the study, 90 pounds, and the average age dropped between 8 and 9 years. ? The study was conducted by dividing the group in half and treat each group with standard care, while the second group also received a single injection of neurotoxin, SP-SAP (P-saporin), close to the tumor site.

similar neurological Many of us are familiar with is the Botox anti-wrinkle injections. Botox works to prevent signals from the nerves to the muscles, so that the muscles no longer contract. ? When certain muscles can not contract, wrinkles appear to soften.

Similarly, SP-SAP works by attaching itself to the nerves of pain sensors. Once attached, the part sap kills nerve. ? This theory, no more pain-sensing nerve and then no more pain.

results of a study

, six weeks into the study, 74% of the dogs was the control group (those receiving standard care only) significant increases in levels of pain and need to be removed from the control group or "blinded" to amended their pain management. ?

In contrast to the control group, only 24% of dogs in the SAP-SP group need to be "unblinded" edits in pain management.

In addition, the dogs in the control group who were receiving standard care only, saw a 6% increase in the intensity of the pain test. ? Dogs who received a single injection SP-SAP saw an increase in the intensity of pain.

and more encouraging, the dogs in the control group experienced a 8% decline in how pain interferes with their daily activities, while the SP-SAP group improved by 5% in their daily activities .

contents

and osteosarcoma affects both dogs and people in the same way, this study is likely to be good news for both humans and dogs. ? Pain relief is critical to improving the quality of life of the patient, and the response to treatment and patient outcomes in general. ? Positive results from this study is likely to raise further investigation in SP- sap and other nerves to manage the pain of osteosarcoma, as well as other diseases with symptoms as well as chronic pain.

to learn more about this study visit: American Society of Anesthesiologists (ASA) (2013, 23 OCT)? Chronic pain in dogs with bone cancer satisfied with the new treatment.

Breakthrough in pain treatment for dogs with osteosarcoma